Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
12,379
Total Claims
$704K
Drug Cost
1,062
Beneficiaries
$663
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 2,621 Pain Management providers
+53%
Opioid rate vs peers
63.2% vs 41.3% avg
+66%
Cost per patient vs peers
$663 vs $399 avg
+32%
Brand preference vs peers
5.0% vs 3.8% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
63.2%
Opioid Rate
7,824
Opioid Claims
$394K
Opioid Cost
12.2%
Long-Acting Rate
This provider's opioid prescribing rate of 63.2% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 614 claims · $290K
Generic: 11,765 claims · $414K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Oxycodone Hcl/Acetaminophen | 2,741 | $120K |
| Hydrocodone/Acetaminophen | 2,455 | $81K |
| Oxycodone Myristate | 169 | $71K |
| Methylnaltrexone Bromide | 17 | $43K |
| Pregabalin | 1,023 | $35K |
| Naloxegol Oxalate | 45 | $23K |
| Oxycodone Hcl | 1,012 | $23K |
| Lidocaine | 119 | $22K |
| Buprenorphine | 55 | $20K |
| Oxycodone Hcl | 47 | $18K |
| Buprenorphine Hcl | 22 | $17K |
| Erenumab-Aooe | 21 | $17K |
| Suvorexant | 23 | $11K |
| Diclofenac Sodium | 92 | $11K |
| Gabapentin | 526 | $9,101 |
Prescribing Profile
49
Unique Drugs
21.0
Anomaly Score
Patient Profile
68
Avg Age
64%
Female
2.25
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data